10-K/A 1 d10ka.htm AMENDMENT NO. 1 TO FORM 10-K Amendment No. 1 to Form 10-K
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-K/A

 


 

Amendment No. 1

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE FISCAL YEAR ENDED: SEPTEMBER 30, 2005

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM              TO             

 

COMMISSION FILE NUMBER: 000-31081

 


 

TRIPATH TECHNOLOGY INC.

(Exact name of registrant as specified in its charter)

 


 

Delaware   77-0407364

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

2560 Orchard Parkway

San Jose, CA 95131

(408) 750-3000

(Address, including zip code, of registrant’s principal executive offices and telephone number, including area code)

 


 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $0.001 par value per share

(Title of Class)

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x

 

Indicate by check mark whether the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨    No  x

 

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ¨    No  x

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the Registrant’s most recently completed second fiscal quarter: $46,235,000

 

There were 55,948,455 shares of Tripath Technology Inc. common stock outstanding on December 13, 2005.

 



Table of Contents

EXPLANATORY NOTE

 

This Annual Report on Form 10-K/A (“Form 10-K/A”) is being filed as Amendment No. 1 to our Annual Report on Form 10-K for the year ended September 30, 2005, which was filed with the Securities and Exchange Commission (the “SEC”) on December 7, 2005 (the “Original Filing”).

 

This Form 10-K/A amends and restates “Item 8. Financial Statements and Supplementary Data” of the Original Filing. Specifically, in the table labeled “Consolidated Statements of Operations” in Item 8, the two line items “Cost of Revenue” and “Provision for slow moving, excess and obsolete inventory” are being added together for the year ended September 30, 2005. The resulting sum of $5,285 (in thousands) for the year ended September 30, 2005 appears in the table in Amendment No. 1 as “Cost of Revenue” and the “Provision for slow moving, excess and obsolete inventory” for the year ended September 30, 2005 is zero in Amendment No. 1. Additionally, also in Item 8, “Note 8—Litigation” has been updated to reflect developments since the Original Filing, and “Note 12—Events (Unaudited) subsequent to the date of the report of the Independent Registered Accounting Firm” has been added to reflect a development since the Original Filing.

 

Pursuant to the rules of the SEC, Item 15 of Part IV of the Original Filing has been amended to include the consent of our independent registered public accounting firm and currently-dated certifications from our principal executive officer and principal financial officer, as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The consent of our independent registered public accounting firm is attached to this Form 10-K/A as Exhibit 23.1. The certifications of our principal executive officer and our principal financial officer are attached to this Form 10-K/A as Exhibits 31.1, 31.2 and 32.1.

 

The other items of the Original Filing have not been amended. This Form 10-K/A does not reflect events occurring after the December 7, 2005 Original Filing or modify or update the disclosures therein in any way other than as required to reflect the amendment as set forth above.


Table of Contents

TRIPATH TECHNOLOGY INC.

 

ANNUAL REPORT ON FORM 10-K/A

FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2005

 

TABLE OF CONTENTS

 

          Page

PART II

ITEM 8.

  

Financial Statements and Supplementary Data

   1
PART IV

ITEM 15.

  

Exhibits and Financial Statement Schedules

   36

SIGNATURES

   37

EXHIBIT INDEX

   38


Table of Contents

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

INDEX TO FINANCIAL STATEMENTS

 

     Page

Reports of Independent Registered Public Accounting Firm

   2

Consolidated Balance Sheets

   6

Consolidated Statements of Operations

   7

Consolidated Statements of Stockholders’ Equity

   8

Consolidated Statements of Cash Flows

   9

Notes to Consolidated Financial Statements

   10

 

1


Table of Contents

Report of Independent Registered Public Accounting Firm

 

Board of Directors and Stockholders

Tripath Technology Inc.

San Jose, CA

 

To The Board of Directors and Stockholders of Tripath Technology Inc.:

 

We have audited the accompanying consolidated balance sheets of Tripath Technology Inc. (the “Company”) and its subsidiary as of September 30 2005 and 2004 and the related consolidated statements of operations, stockholders’ equity, and cash flows for the year ended September 30, 2005, the nine month period ended September 30, 2004 and the year ended December 31, 2003. Our audit also included the financial statement schedule listed in the Index at Item 15(a). These financial statements and financial statement schedules are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and financial statement schedules based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Tripath Technology Inc. at September 30, 2005 and 2004, and the consolidated results of their operations and their cash flows for the year ended September 30, 2005, the nine month period ended September 30, 2004 and the year ended December 31, 2003, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the financial statement schedule as of September 30, 2005 and 2004 and for each of the two years in the period then ended, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company’s significant recurring operating losses and accumulated deficit raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of the Tripath Technology Inc.’s internal control over financial reporting as of September 30, 2005, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) and our report dated November 23, 2005 expressed an unqualified opinion on management’s assessment and an adverse opinion on the effectiveness of internal control over financial reporting.

 

/s/    STONEFIELD JOSEPHSON, INC.

 

San Francisco, California

November 23, 2005, except as to the fourth, seventh and ninth paragraphs of Note 8, which are as of December 15, 2005.

 

2


Table of Contents

Report of Independent Registered Public Accounting Firm On Internal Controls Over Financial Reporting

 

Board of Directors and Stockholders

Tripath Technology Inc.

San Jose, CA

 

To The Board of Directors and Stockholders of Tripath Technology Inc.:

 

We have audited management’s assessment, included in the accompanying Management’s Report on Internal Control over Financial Reporting, that Tripath Technology Inc. did not maintain effective internal control over financial reporting as of September 30, 2005, because of the effects of the material weaknesses identified in management’s assessment, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Tripath Technology Inc.’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the Company’s internal control over financial reporting based on our audit.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

A material weakness is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected. The following material weaknesses have been identified and included in management’s assessment:

 

    Lack of sufficient personnel and technical accounting and financial reporting expertise within the Company’s accounting and finance function. As of September 30, 2005, the Company did not have sufficient personnel and technical accounting and financial reporting expertise within its accounting function to sufficiently address relatively complex transactions and/or accounting and financial reporting issues that arise from time to time in the course of its operations. This situation was exacerbated by the additional demands placed upon the Company’s accounting and finance personnel as it worked to meet the internal control requirements under Section 404 of the Sarbanes-Oxley Act of 2002 and the turnover in the personnel in the accounting and finance functions.

 

3


Table of Contents

This material weakness resulted in adjustments, some of which are material to the Company’s fiscal year 2005 annual financial statements. Further, this material weakness could result in material misstatements to the Company’s future annual or interim financial statements that would not be prevented or detected.

 

    Inadequate controls over the period-end financial reporting process. As of September 30, 2005, the Company’s Chief Financial Officer was responsible for preparing or compiling certain critical portions of the quarterly and annual internal financial information and was also responsible for performing a review of this information to monitor the results of operations. This review represents an important detective control in the Company’s internal control over financial reporting. Because there was no separate independent detailed review of this critical financial information, there is a risk that inaccurate information may be reported and misstatements may not be identified. Also, due to the turnover in the personnel in the accounting and finance functions many controls over period-end financial reporting were not properly followed. This material weakness resulted in adjustments, some of which are material to the Company’s fiscal year 2005 annual financial statements. Further, this material weakness could result in material misstatements to the Company’s future annual or interim financial statements that would not be prevented or detected.

 

    Inadequate controls in the area of inventory. As of September 30, 2005, there were certain instances in which the Company’s standard costing was not applied correctly. In addition, in certain instances one individual had authority for certain activities which should be segregated, such as processing of point-of-sale reports, inventory reports and invoicing. The Company did not have adequate oversight and review of these personnel to compensate for the inadequate segregation of duties. These weaknesses individually represent significant deficiencies and, in the aggregate, represent a material weakness. This material weakness resulted in adjustments, some of which are material to the Company’s fiscal year 2005 annual financial statements. Further, this material weakness could result in material misstatements to the Company’s future annual or interim financial statements that would not be prevented or detected.

 

    Inadequate controls in the area of fixed assets. As of September 30, 2005, management did not ensure that the Company’s Fixed Asset Policy was strictly enforced, including instances where the detail listing of assets was not comprehensive, the capitation policy was not followed and depreciation expense was not calculated correctly. In addition, the Company did not maintain adequate segregation of duties among members of its fixed asset department. In several instances, the Company had the same personnel performing duties that were not compatible. Furthermore, management did not have adequate oversight and review of these personnel to compensate for the inadequate segregation of duties. These weaknesses individually represent significant deficiencies and, in the aggregate, represent a material weakness. This material weakness resulted in adjustments, some of which are material to the Company’s fiscal year 2005 annual financial statements. Further, this material weakness could result in material misstatements to the Company’s future annual or interim financial statements that would not be prevented or detected.

 

    Inadequate controls in the areas of reconciliation of accrued expenses. As of September 30, 2005, there were certain instances in which the company failed to reconcile the supporting documentation for accrued expenses to the general ledger control account impacting the Company’s ability to ensure all transactions flowing through the accounts are properly reflected in the recorded account balances. These weaknesses individually represent significant deficiencies and, in the aggregate, represent a material weakness. This material weakness resulted in adjustments, some of which are material to the Company’s fiscal year 2005 annual financial statements. Further, this material weakness could result in material misstatements to the Company’s future annual or interim financial statements that would not be prevented or detected.

 

   

Inadequate controls in the area of payroll/human resources. As of September 30, 2005, management did not ensure that the Company’s review of payroll reports was strictly enforced, including tracking of vacation and tracking of new and terminated employees. In addition, the Company did not maintain adequate segregation of duties among members of its payroll/human resource departments. In several instances, the Company had the same personnel performing duties that were not compatible.

 

4


Table of Contents
 

Furthermore, management did not have adequate oversight and review of these personnel to compensate for the inadequate segregation of duties. These weaknesses individually represent significant deficiencies and, in the aggregate, represent a material weakness. This material weakness resulted in adjustments, some of which are material to the Company’s fiscal year 2005 annual financial statements. Further, this material weakness could result in material misstatements to the Company’s future annual or interim financial statements that would not be prevented or detected.

 

    Inadequate controls in the area of information technology. As of September 30, 2005, the Company did not maintain effective controls over access to the accounting system and in some cases did not maintain complete documentation regarding these access rights. Specifically, certain of the Company’s accounting users with financial, accounting and reporting responsibilities also had inappropriate access to financial application programs and data. Such access was not in compliance with segregation of duties requirements nor was this access independently monitored. In addition, the documentation regarding access privileges of certain individuals to the accounting system was not reflective of actual access privileges. Further, the Company did not maintain adequate controls in the area of system development. These weaknesses individually represent significant deficiencies and, in the aggregate, represent a material weakness. This material weakness did not result in adjustments to the Company’s fiscal year 2005 annual financial statements. However, this material weakness could result in material misstatements to the Company’s future annual or interim financial statements that would not be prevented or detected.

 

    Lack of internal control reports (under SAS 70) from critical external service providers whose processes are significant to the Company’s internal control over financial reporting. As of September 30, 2005, the Company was unable to obtain proper “Report on Controls Placed in Operation and Test of Operating Effectiveness” (in accordance with Statement of Auditing Standards No. 70) from two external service providers, and the Company did not have alternative procedures to test user controls, test controls at service organizations or request the service organization auditor to perform agreed upon procedures. These include the providers of the Company’s payroll service, and the stock management provider. The services performed by these service providers were deemed material and significant to the Company’s business and accurate financial reporting. This material weakness did not result in adjustments to the Company’s fiscal year 2005 annual financial statements. However, this material weakness could result in material misstatements to the Company’s future annual or interim financial statements that would not be prevented or detected by the Company’s system of internal control over financial reporting.

 

These material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of Tripath Technology Inc.’s consolidated financial statements as of and for the year ended September 30, 2005, and this report does not affect our report dated November 23, 2005 on those consolidated financial statements.

 

In our opinion, management’s assessment that Tripath Technology Inc. did not maintain effective internal control over financial reporting as of September 30, 2005, is fairly stated, in all material respects, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Also, in our opinion, because of the effects of the material weaknesses described above on the achievement of the objectives of the control criteria, Tripath Technology Inc. has not maintained effective internal control over financial reporting as of September 30, 2005, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

 

We do not express an opinion or any other form of assurance on management’s statements regarding corrective actions taken by the Company after September 30, 2005.

 

/s/    STONEFIELD JOSEPHSON, INC.

 

San Francisco, California

November 23, 2005

 

5


Table of Contents

TRIPATH TECHNOLOGY INC.

 

CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

 

     September 30,
2005


   

September 30,
2004

Restated
(Note 9)


 

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 716     $ 6577  

Restricted cash

     162       762  

Accounts receivable, net of allowance for doubtful accounts of $0 and $50 at September 30, 2005 and 2004 respectively

     1,010       1,019  

Inventories, net

     5,457       3,939  

Prepaid expenses and other current assets

     1,512       212  
    


 


Total current assets

     8,857       12,509  

Property and equipment, net

     875       1,674  

Other assets

     122       123  
    


 


Total assets

   $ 9,854     $ 14,306  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Accounts payable

   $ 3,488     $ 2,908  

Current portion of capital lease obligations

     215       664  

Current portion of deferred rent

     305       266  

Accrued expenses

     2,899       764  

Deferred distributor revenue

     1,202       1,075  

Warrant Liability

     396       —    
    


 


Total current liabilities

     8,505       5,677  
    


 


Deferred rent

     167       471  

Capital lease obligations

     21       100  
    


 


Total long term liabilities

     188       571  
    


 


Commitments and contingencies (Note 7)

                

Stockholders’ equity:

                

Preferred stock, $0.001 par value, 5,000,000 shares authorized; 0 shares issued and outstanding

     —         —    

Common stock, $0.001 par value, 100,000,000 shares authorized; 55,410,722 and 50,043,158 shares issued and outstanding at September 30, 2005 and September 30, 2004 respectively

     55       49  

Additional paid-in capital

     202,310       199,333  

Deferred stock-based compensation

     —         (95 )

Other comprehensive expense

     (3 )     —    

Accumulated deficit

     (201,201 )     (191,229 )
    


 


Total stockholders’ equity

     1,161       8,058  
    


 


Total liabilities and stockholders’ equity

   $ 9,854     $ 14,306  
    


 


 

The accompanying notes are an integral part of these consolidated financial statements.

 

6


Table of Contents

TRIPATH TECHNOLOGY INC.

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

 

     Year Ended
September 30,
2005


   

Nine Months
Ended
September 30,
2004

Restated

2004


    Year Ended
December 31,
2003


 

Revenue

   $ 10,761     $ 9,169     $ 13,891  

Cost of revenue

     5,285       7,415       9,467  

Provision for slow moving, excess and obsolete inventory

     —         4,316       243  
    


 


 


Gross profit (loss)

     5,476       (2,562 )     4,181  
    


 


 


Operating expenses:

                        

Research and development

     7,413       5,521       6,874  

Selling, general and administrative

     8,586       3,556       4,544  
    


 


 


Total operating expenses

     15,999       9,077       11,418  
    


 


 


Loss from operations

     (10,523 )     (11,639 )     (7,237 )

Net gain on revaluation of warrant liability

     570       —         —    

Interest and other income (expense), net

     (19 )     (26 )     22  
    


 


 


Net loss

     (9,972 )     (11,665 )     (7,215 )
    


 


 


Basic and diluted net loss per share

   $ (0.19 )   $ (0.25 )   $ (0.17 )
    


 


 


Number of shares used to compute basic and diluted net loss per share

     53,206       46,541       41,993  
    


 


 


 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

7


Table of Contents

TRIPATH TECHNOLOGY INC.

 

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)

 

    Common
Shares


  Amount

  Additional
Paid in
Capital


   

Deferred

Stock-based

Compensation


    Accumulated
Deficit


    Other
Comprehensive
Expense


    Total
Stockholders’
Equity


 

Balance at December 31, 2002

  41,327   $ 41   $ 187,835     $ (91 )   $ (172,349 )           $ 15,436  

Issuance of common stock upon exercise of stock options

  660     —       498       —         —                 498  

Issuance of common stock upon exercise of warrants

  1,896     2     3,111                               3,113  

Issuance of common stock through the ESPP

  27     —       7       —         —                 7  

Reversal of previously recognized compensation due to forfeitures

  —       —       (117 )     10       —                 (107 )

Deferred stock-based compensation

  —       —       —         (324 )     —                 (324 )

Amortization of deferred stock-based compensation

  —       —       —         188       —                 188  

Issuance of restricted stock

  1,800     2     322       —         —                 324  

Net Loss

  —       —       —         —         (7,215 )             (7,215 )
   
 

 


 


 


 


 


Balance at December 31, 2003

  45,710     45     191,656       (217 )     (179,564 )             11,920  

Issuance of common stock upon exercise of stock options

  535     1     345       —         —                 346  

Issuance of common stock upon exercise of warrants

  1,211     1     2,347       —         —                 2,348  

Issuance of common stock through the ESPP

  87     —       43       —         —                 43  

Issuance of common stock

  2,500     2     4,998       —         —                 5,000  

Stock issuance cost

  —       —       (56 )     —         —                 (56 )

Amortization of deferred stock-based compensation

  —       —       —         122       —                 122  

Net loss (restated)

  —       —       —         —         (11,665 )             (11,665 )
   
 

 


 


 


 


 


Balance at September 30, 2004 (restated)

  50,043     49     199,333       (95 )     (191,229 )             8,058  

Issuance of common stock upon exercise of stock options

  425     1     135       —         —                 136  

Deferred stock-based compensation

  —       —       19       —         —                 19  

Issuance of common stock through the ESPP

  110     —       51       —         —                 51  

Issuance of common stock

  4,833     5     3,380       —         —                 3,385  

Stock issuance costs

  —       —       (608 )     —         —                 (608 )

Amortization of deferred stock-based compensation

  —       —       —         95       —                 95  

Foreign currency translation adjustment

                                      (3 )     (3 )

Net loss

  —       —       —         —         (9,972 )             (9,972 )
   
 

 


 


 


 


 


Balance at September 30, 2005

  55,411   $ 55   $ 202,310     $ —       $ (201,201 )   $ (3 )   $ 1,161  
   
 

 


 


 


 


 


 

The accompanying notes are an integral part of these consolidated financial statements.

 

8


Table of Contents

TRIPATH TECHNOLOGY INC.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

     Year Ended
September 30,
2005


   

Nine Months
Ended
September 30,
Restated

2004


    Year Ended
December 31,
2003


 

Cash flows from operating activities:

                        

Net loss

   $ (9,972 )   $ (11,665 )   $ (7,215 )

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

                        

Change due to revaluation of warrant liability

     (570 )     —         —    

Depreciation and amortization

     895       829       1,206  

Allowance for doubtful accounts

     (111 )     —         —    

Provision for slow moving excess and obsolete inventory

     (4,026 )     4,316       243  

Stock-based compensation

     95       122       81  

Changes in assets and liabilities:

                        

Accounts receivable

     120       1,012       (570 )

Inventories

     2,508       (2,681 )     (565 )

Prepaid expenses and other assets

     (1,299 )     9       546  

Accounts payable

     580       (1,151 )     1,674  

Accrued expenses

     2,135       162       (468 )

Deferred distributor revenue

     127       (50 )     499  

Deferred rent

     (265 )     40       502  
    


 


 


Net cash used in operating activities

     (9,783 )     (9,057 )     (4,067 )
    


 


 


Cash flows from investing activities:

                        

Restricted cash

     600       (101 )     (175 )

Purchase of property and equipment

     (96 )     (606 )     (312 )
    


 


 


Net cash provided by (used in) investing activities

     504       (707 )     (487 )
    


 


 


Cash flows from financing activities:

                        

Proceeds from issuance of common stock under ESPP and upon exercise of options

     —         389       505  

Issuance of common stock upon exercise of warrants

     —         2,348       3113  

Issuance of common stock upon sale of sale of common stock, net of issuance costs

     3,949       4,944       —    

Principal payments on capital lease obligations

     (528 )     (291 )     (225 )
    


 


 


Net cash provided by financing activities

     3,421       7,390       3,393  
    


 


 


Effect of exchange rate changes on cash and cash equivalents

     (3 )     —         —    

Net decrease in cash and cash equivalents

     (5,861 )     (2,374 )     (1,161 )

Cash and cash equivalents at beginning of year

     6,577       8,951       10,112  
    


 


 


Cash and cash equivalents at end of year

   $ 716     $ 6,577     $ 8,951  
    


 


 


Supplemental disclosure of cash flow information:

                        

Interest Income (Expense)

   $ (25 )   $ (26 )   $ 23  

Non-cash investing and financing activities:

                        

Property and equipment acquired by capital lease

   $ —       $ —       $ 317  

Conversion of preferred stock into common stock

   $ —       $ —       $ —    

Issuance of common stock warrants

   $ —       $ —       $ —    

 

The accompanying notes are an integral part of these consolidated financial statements.

 

9


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1—THE COMPANY AND BASIS OF PRESENTATION:

 

The Company

 

Tripath Technology Inc. (the “Company” or “Tripath”) was incorporated in California in July 1995. The Company was reincorporated in Delaware in July 2000. The Company designs, develops and markets integrated circuit devices for the Consumer and PC Convergence, DSL and Wireless markets. On August 1, 2000, the Company completed its initial public offering of 5 million shares of common stock at $10.00 per share.

 

Basis of Presentation

 

The consolidated financial statements include the accounts of Tripath and its wholly owned subsidiary, Tripath Technology Japan Ltd. All significant intercompany accounts and transactions have been eliminated. Accounts denominated in foreign currency have been remeasured using the U.S. dollar as the functional currency.

 

On November 14, 2004, Tripath’s Board of Directors approved a change in the Company’s fiscal year end from December 31 to September 30, effective as of September 30, 2004.

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods and such differences could be material.

 

Going Concern

 

The Company’s consolidated financial statements have been prepared on the basis of a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred substantial losses and has experienced negative cash flow since inception and has an accumulated deficit of $201.2 million at September 30, 2005. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

Beginning in August 2001, the Company instituted programs to reduce expenses including reducing headcount from 144 employees at the end of July 2001 to 56 employees at the end of December 2003 and reducing employee salaries by 10 percent. In September 2002 the Company relocated its headquarters which reduced rent expense and canceled its D&O policy which reduced insurance expense. These actions resulted in significant cost savings in 2003. The Company reduced its cash used in operating activities from approximately $13 million in 2002 to approximately $4 million in 2003. However, for the nine months ended September 30, 2004, cash used in operating activities increased to $9.1 million and for the year ended September 30, 2005 the Company used $9.8 million in cash.

 

During 2003 warrants were exercised which resulted in the Company receiving proceeds totaling approximately $3.1 million. During 2004, the Company received proceeds of approximately $2.3 million from the exercise of outstanding warrants and $5 million from the sale of common stock. During 2005, the Company received proceeds of approximately $4.4 million from the sale of common stock. At September 30, 2005, the Company had working capital of $0.4 million, including cash of $0.9 million.

 

The Company will require more cash during 2006 to fund its operations and management believes that such additional cash requirements could be met by first obtaining additional financing or by taking measures to reduce

 

10


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

operating expenses such as reducing headcount or canceling research and development projects. However, the Company may not be able to obtain additional funds on terms that would be favorable to its stockholders and the Company, or at all. The Company’s long term prospects are dependent upon obtaining sufficient financing as needed to fund current working capital needs and future growth, and ultimately on achieving profitability.

 

Foreign Currency Translation

 

The U.S. dollar is the functional currency for the Company’s Japanese wholly-owned subsidiary. Assets and liabilities that are not denominated in the functional currency are remeasured into U.S. dollars and the resulting gains or losses are included in “Interest and other income, net.” Such gains or losses have not been material for any period presented.

 

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Securities and Exchange Commission Staff Accounting Bulletin No. 104 (“SAB 104”), “Revenue Recognition in Financial Statements”. The Company recognizes revenue when all of the following criteria are met: 1) there is persuasive evidence that an arrangement exists, 2) delivery of goods has occurred, 3) the sales price is fixed or determinable, and 4) collectibility is reasonably assured. The following policies apply to the Company’s major categories of revenue transactions.

 

Sales to OEM Customers: Under the Company’s standard terms and conditions of sale, title and risk of loss transfer to the customer at the time product is delivered to the customer, FOB shipping point, and revenue is recognized accordingly. The Company accrues the estimated cost of post-sale obligations, including basic product warranties or returns, based on historical experience. The Company has experienced minimal warranty or other returns to date.

 

Sales to Distributors: Sales to distributors are made under arrangements allowing limited rights of return, generally under product warranty provisions, stock rotation rights and price protection on products unsold by the distributor. In addition, the distributor may request special pricing and allowances which may be granted subject to the company’s approval. As a result of these return rights and potential pricing adjustments, the Company generally defers recognition of revenue until such time that the distributor sells product to its customer based upon receipt of point-of-sale reports from the distributor.

 

Costs related to shipping and handling are included in cost of revenue for all periods presented.

 

Allowance for Doubtful Accounts

 

The Company provides an allowance for doubtful accounts to ensure trade receivables are not overstated due to un-collectibility. The collectibility of the Company’s receivables is evaluated based on a variety of factors, including the length of time receivables are past due, indication of the customer’s willingness to pay, significant one-time events and historical experience. An additional reserve for individual accounts is recorded when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy filings or substantial deterioration in the customer’s operating results or financial position. If circumstances related to the Company’s customers change, estimates of the recoverability of receivables would be further adjusted.

 

Cash and cash equivalents and restricted cash

 

The Company considers all highly liquid investments with a maturity of three months or less from the date of purchase to be cash equivalents. Cash and cash equivalents consist of cash and money market funds, the fair value of which approximates cost.

 

11


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

The following table summarizes the Company’s cash and cash equivalents (in thousands):

 

     September 30,
2005


   September 30,
2004


Cash and cash equivalents:

             

Cash

   $ 530    $ 942

Money market funds

     186      5,635
    

  

     $ 716    $ 6,577
    

  

 

At September 30, 2005 and September 30, 2004, the Company had $0.2 million and $0.8 million in restricted cash, respectively. The restricted cash represents monies held in a separate money market account that collateralize standby letters of credit that have been issued (see Note 7).

 

Fair value of financial instruments

 

Carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values due to their relative short maturities and based upon comparable market information available at the respective balance sheet dates. The Company does not hold or issue financial instruments for trading purposes.

 

Concentration of credit risk and significant customers

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. Substantially all of the Company’s cash and cash equivalents are invested in highly-liquid money market funds. The Company sells its products through distributors and directly to original equipment manufacturers. The Company performs ongoing credit evaluations of its customers and maintains an allowance for potential credit losses, as considered necessary by management. Credit losses to date have been consistent with management’s estimates. During the year ended September 30, 2005, the nine months ended September 30, 2004 and year ended December 31, 2003 the Company wrote-off bad debts which had previously been reserved totaling approximately $0, $0, and $295,000, respectively.

 

The following table summarizes sales to end customers comprising 10 percent or more of the Company’s total revenue for the periods indicated:

 

     % of Revenue for the
Year Ended
September 30, 2005


   

% of Revenue for the
Nine Months Ended
September 30, 2004

Restated 2004


    % of Revenue for the
Year Ended
December 31, 2003


 

Customer A

   40 %   28 %   24 %

Customer B

   16 %   19 %   —   %

Customer C

   12 %   9 %   18 %

Customer D

   —   %   —   %   15 %

 

The Company’s accounts receivable were concentrated with 3 customers at September 30, 2005 representing 40 percent, 16 percent and 12 percent of aggregate gross receivables, three customers at September 30, 2004 representing 28 percent, 19 percent and 9 percent of aggregate gross receivables and three customers at December 31, 2003 representing 24 percent, 18 percent and 15 percent of aggregate gross receivables.

 

12


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Inventories

 

Inventories are stated at the lower of cost or market. This policy requires the Company to make estimates regarding the market value of the Company’s inventory, including an assessment of excess or obsolete inventory. The Company determines excess and obsolete inventory based on an estimate of the future demand and estimated selling prices for the Company’s products within a specified time horizon, generally 12 months. The estimates the Company uses for expected demand are also used for near-term capacity planning and inventory purchasing and are consistent with the Company’s revenue forecasts. Actual demand and market conditions may be different from those projected by the Company’s management. If the Company’s unit demand forecast is less than the Company’s current inventory levels and purchase commitments, during the specified time horizon, or if the estimated selling price is less than the Company’s inventory value, the Company will be required to take additional excess inventory charges or write-downs to net realizable value which will decrease the Company’s gross margin and net operating results in the future. During the quarter ended March 31, 2002, the Company recorded a provision for excess inventory of approximately $5 million primarily related to excess inventory for the Company’s TA2022 product as a result of a decrease in forecasted sales for this product. In 2004, the Company increased the inventory reserves by an additional $4.3 million from $4.9 million to $9.2 million to account for slow moving, excess, and obsolete inventory. The additional inventory charge related to slow-moving and excess inventory for our TA1101B, TA3020, TA2041, TA2022 and leaded TA2024 products, the TK2350, TK2051, TK2150, TK2050 and TK2052 chipsets, and Kauai 2BB and U461 die based on a decline in forecasted sales for these parts. These components and finished goods did not have a market or sales forecast based on customer demand that could support the number of units in inventory at that time. During the year ended September 30, 2005, the Company released a net amount of approximately $4.0 million of inventory reserves for products sold that were previously reserved for. These releases were due to the Company’s end-customers experiencing significant growth which resulted in sales of previously written down inventory. In addition during 2005, certain of the Company’s customers’ products had experienced growth beyond previously estimated levels.

 

Inventory purchase commitment losses

 

The Company accrues for estimated losses on non-cancelable purchase orders. The estimated losses result from anticipated future sale of products for sales prices less than the estimated cost to manufacture. Inventory purchase commitment losses accrued at September 30, 2005, September 30, 2004 and December 31, 2003 were $0.

 

Research and development expenses

 

Research and development costs are charged to expense as incurred.

 

Property and equipment

 

Property and equipment, including leasehold improvements, are stated at historical cost, less accumulated depreciation and amortization. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the estimated useful lives of the assets or the term of the lease. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:

 

Furniture and fixtures

   5 years

Software

   Shorter of 3-5 years or term of license

Equipment

   2-5 years

 

13


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. An impairment loss is recognized if the sum of the expected future cash flows (undiscounted and before interest) from the use of the assets is less than the net book value of the asset. The amount of the impairment loss, if any, will generally be measured as the difference between net book value of the assets and their estimated fair values.

 

Comprehensive income

 

Statement of Financial Accounting Standards No. 130, “Reporting Comprehensive Income,” establishes standards for reporting and displaying comprehensive income and its components in a full set of general-purposes financial statements. There was no difference between the Company’s net loss and its total comprehensive loss for the year ended September 30, 2005, the nine months ended September 30, 2004, and for the year ended December 31, 2003.

 

Accounting for stock-based compensation

 

At September 30, 2005, the Company has two stock-based employee compensation plans, which are described more fully in Note 5. The Company accounts for those plans under the recognition and measurement principles of APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and related Interpretations. No stock-based employee compensation cost related to stock options is reflected in net income for the year ended September 30, 2005, the nine months ended September 30, 2004 and year ended December 31, 2003, as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of FASB Statement No. 123, “Accounting for Stock-Based Compensation”, to stock-based employee compensation.

 

     Year Ended
September 30,
2005


   

Nine Months
Ended
September 30,
2004

Restated


    Year Ended
December 31,
2003


 

Net loss applicable to common stockholders, as reported

   $ (9,972 )   $ (11,665 )   $ (7,215 )

Total stock-based employee compensation expense included in the net loss, determined under the recognition and measurement principles of APB Opinion No. 25

     95       122       81  

Total stock-based employee compensation expense determined under fair value based method for all awards

     (3,657 )     (2,378 )     (1,211 )
    


 


 


Pro forma net loss applicable to common stockholders

   $ (13,534 )   $ (13,921 )   $ (8,345 )
    


 


 


As reported

   $ (0.19 )   $ (0.25 )   $ (0.17 )
    


 


 


Pro forma

   $ (0.25 )   $ (0.30 )   $ (0.20 )
    


 


 


 

The fair value for these options was estimated using the Black-Scholes option pricing model.

 

The Black-Scholes option pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Option pricing models require the input of highly subjective assumptions, including the expected stock price volatility. Accordingly, option pricing models may not necessarily provide a reliable single measure of the fair value of options.

 

14


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

The fair value of options at the date of grant was estimated on the date of grant based on the method prescribed by SFAS No. 123. The following table summarizes the estimated fair value of options and assumptions used in the SFAS No. 123 calculations for stock option plans:

 

     Year Ended
September 30,
2005


    Nine Months
Ended
September 30,
2004


    Year Ended
December 31,
2003


 

Estimated fair value

   $ .62     $ 1.12     $ 0.73  

Expected lives (in years)

     5       5       5  

Volatility

     150 %     155 %     157 %

Risk-free interest rate

     3.94 %     3.29 %     2.96 %

Dividend yield

     —         —         —    

 

The following table summarizes the estimated fair value of employees’ purchase rights and assumptions used in the SFAS No. 123 calculations:

 

    

Year Ended
September 30,

2005


    Nine Months
Ended
September 30,
2004


    Year Ended
December 31,
2003


 

Estimated fair value

   $ .31     $ 2.91     $ 0.15  

Expected lives (in years)

     0.5       0.5       0.5  

Volatility

     150 %     155 %     157 %

Risk-free interest rate

     3.94 %     3.29 %     2.96 %

Dividend yield

     —         —         —    

 

The following tables sets forth, for each of the periods presented, deferred stock-based compensation recorded and the amortization of deferred stock-based compensation (in thousands):

 

     Year Ended
September 30,
2005


   Nine Months
Ended
September 30,
2004


   Year Ended
December 31,
2003


 

Deferred stock-based compensation

   $ —      $ —      $ (324 )

Amortization of deferred stock-based compensation

     95      122      188  

Reversal of previously recognized compensation due to forfeitures

     —        —        (107 )

 

Unamortized deferred stock-based compensation at September 30, 2005, September 30, 2004 and December 31, 2003 was $0, $95,000 and $217,000, respectively.

 

Stock-based compensation attributable to individuals that worked in the following functions is as follows (in thousands):

 

     Year Ended
September 30,
2005


   Nine Months
Ended
September 30,
2004


   Year Ended
December 30,
2003


Manufacturing/operations (cost of revenues)

   $ —      $ —      $ 4

Research and development

     —        1      20

Selling, general and administrative

     95      121      57
    

  

  

Total stock-based compensation

   $ 95    $ 122    $ 81
    

  

  

 

15


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Segment and geographic information

 

The Company has determined that it has one reportable business segment: the design, license and marketing of integrated circuits.

 

The following is a geographic breakdown of the Company’s sales by shipping destination for the following periods:

 

     Year Ended
September 30,
2005


  

Nine Months
Ended
September 30,
2004

Restated 2004


   Year Ended
December 31,
2003


United States

   $ 628    $ 1,034    $ 909

Japan

     4,888      4,927      6,117

Singapore

     21      142      522

Taiwan

     1,167      222      1,325

China

     1,393      1,424      797

Korea

     718      —        3,146

Rest of world

     1,946      1,420      1,075
    

  

  

     $ 10,761    $ 9,169    $ 13,891
    

  

  

 

Net property and equipment by country was as follows:

 

     September 30,
2005


  

September 30,

2004


   December 31,
2003


United States

   $ 324    $ 891    $ 1,532

Korea

     264      389      317

Malaysia

     282      362      —  

Japan

     5      32      48
    

  

  

     $ 875    $ 1,674    $ 1,897
    

  

  

 

Recent Accounting Pronouncements

 

In November 2004, the FASB issued SFAS No. 151, “Inventory Costs—an amendment of ARB No. 43, Chapter 4,” or “SFAS 151.” SFAS 151 amends ARB 43, Chapter 4 to clarify that “abnormal” amounts of idle freight, handling costs and spoilage should be recognized as current period charges. SFAS 151 is effective for inventory costs incurred during fiscal years beginning after June 15, 2005. We do not anticipate that the adoption of this standard will have a material impact on our consolidated financial statements.

 

In December 2004, the FASB issued SFAS No. 153 “Exchanges of Non-monetary Assets—an amendment of APB opinion No. 29,” or SFAS 153. SFAS 153 clarifies that exchanges of non-monetary assets should be measured based on the fair value of the assets exchanged, with a general exception for exchanges that have no commercial substance. SFAS 153 is effective for non-monetary asset exchanges occurring in fiscal periods beginning after June 15, 2005. We do not anticipate that the adoption of this standard will have a material impact on our consolidated financial statements.

 

In December 2004, the FASB revised SFAS No. 123 (SFAS 123(R)). SFAS 123(R), “Share-Based Payment”, requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Pro forma disclosure is no longer an alternative to financial statement recognition. SFAS 123(R) is effective for periods beginning after June 15, 2005. On

 

16


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

April 14, 2005, the SEC announced the adoption of a new rule that amended the compliance dates for SFAS 123(R). Under the new rule, companies are allowed to implement SFAS 123(R) at the beginning of the next fiscal year, instead of the next reporting period, that begins after June 15, 2005. We are required to comply with SFAS 123(R) beginning with our fiscal quarter ending December 31, 2005. SFAS 123(R) provides transition alternatives for public companies to restate prior interim periods or prior years. We are still evaluating the transition provisions allowed by SFAS 123(R).

 

In March 2005, the SEC released SEC Staff Accounting Bulletin No. 107, “Share-Based Payment” (“SAB 107”). SAB 107 provides the SEC staff’s position regarding the application of SFAS 123(R) and certain SEC rules and regulations, and also provides the staff’s views regarding the valuation of share-based payment arrangements for public companies. We are currently reviewing the effect, if any, that the application of SAB 107 will have on our financial position and results of operations.

 

In March 2005, the FASB issued FSP No. 46(R)-5, Implicit Variable Interests under FASB Interpretation No. 46 (revised December 2003), Consolidation of Variable Interest Entities (FSP 46(R)-5), which provides guidance for a reporting enterprise on whether it holds an implicit variable interest in a variable interest entity (VIE) or potential VIE when specific conditions exist. FSP 46(R)-5 became applicable to the Company in the quarter ended June 30, 2005. FSP 46(R) had no impact on the Company’s consolidated results of operations and financial condition as of September 30, 2005.

 

In March 2005, the FASB issued FIN 47, Accounting for Conditional Asset Retirement Obligations, an interpretation of FASB Statement No. 143 (FIN 47), which requires an entity to recognize a liability for the fair value of a conditional asset retirement obligation when incurred if the liability’s fair value can be reasonably estimated. FIN 47 is effective for fiscal years ending after December 15, 2005. The Company is currently evaluating the effect that the adoption of FIN 47 will have on the Company’s consolidated results of operations and financial condition, but does not expect it to have a material impact.

 

In May 2005, the FASB issued SFAS No. 154 “Accounting Changes and Error Corrections—a replacement of APB Opinion No. 20, and FASB Statement No. 3.” (SFAS 154). SFAS 154 replaces APB Opinion No. 20, Accounting Changes, and FASB Statement No. 3, Reporting Accounting Changes in Interim Financial Statements, and changes the requirements for the accounting for and reporting of a change in accounting principle. This statement applies to all voluntary changes in accounting principle. It also applies to changes required by an accounting pronouncement in the unusual instance that the pronouncement does not include specific transition provisions. When a pronouncement includes specific transition provisions, those provisions should be followed. SFAS 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 31, 2005. We do not anticipate that the adoption of this standard will have a material impact on our consolidated financial statements.

 

In December 2004, the FASB issued and made effective two Staff Positions (FSP) that provide accounting guidance on how companies should account for the effect of the American Jobs Creation Act of 2004 that was signed into law on October 22, 2004. In FSP FAS 109-1, “Application of FASB Statement No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004,” the FASB concluded that the special tax deduction for domestic manufacturing, created by the new legislation, should be accounted for as a “special deduction” instead of a tax rate reduction. As such, the special tax deduction for domestic manufacturing is recognized no earlier than the year in which the deduction is taken on the tax return. FSP FAS 109-2, “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004,” allows additional time to evaluate the effects of the new legislation on any plan for reinvestment or repatriation of foreign earnings for purposes of applying FASB Statement No. 109. The Company does not anticipate that this legislation will impact its results of operations or financial condition.

 

17


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Net loss per share

 

Basic net loss per share is computed by dividing the net loss available to common stockholders for the period by the weighted average number of common stock outstanding during the period. Diluted net loss per share is computed based on the weighted average number of common stock and dilutive potential common stock outstanding. The calculation of diluted net loss per share excludes potential common stock if the effect is anti-dilutive. Potential common stock consists of incremental common stock issuable upon the exercise of stock options, shares issuable upon conversion of convertible preferred stock and common stock issuable upon the exercise of common stock warrants.

 

The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands, except per share amounts):

 

     Year Ended
September 30,
2005


   

Nine Months Ended
September 30, 2004

Restated


    Year Ended
December 31,
2003


 

Numerator:

                        

Net loss applicable to common stockholders

   $ (9,972 )   $ (11,665 )   $ (7,215 )
    


 


 


Denominator:

                        

Weighted average common stock

     53,206       46,541       41,993  
    


 


 


Net loss per share:

                        

Basic and diluted

   $ (0.19 )   $ (0.25 )   $ (0.17 )
    


 


 


 

The following table sets forth potential shares of common stock that are not included in the diluted net loss per share calculation above because to do so would be anti-dilutive for the periods presented (in thousands):

 

     Year Ended
September 30,
2005


   Nine Months
Ended
September 30,
2004


  

Year Ended

December 31,
2003


Common stock options

   10,403    11,418    8,501

Common stock under Employee Stock Purchase Plan

   125    234    322

Common stock warrants

   968    16    1,229

Restricted Stock

   1,800    1,800    1,800

 

18


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

NOTE 3—BALANCE SHEET COMPONENTS (in thousands):

 

     September 30,
2005


   

September 30,
2004

Restated


    December 31,
2003


 

Accounts receivable, net:

                        

Accounts receivable

   $ 1,142     $ 1,089     $ 2,101  

Less: allowance for sales returns

     (132 )     (20 )     (10 )

Less: allowance for doubtful accounts

     —         (50 )     (50 )
    


 


 


     $ 1,010     $ 1,019     $ 2,041  
    


 


 


Inventories, net:

                        

Raw materials

   $ 4,805     $ 6,668     $ 5,148  

Work-in-process

     986       847       1,007  

Finished goods

     3,913       4,938       3,551  

Inventory held by distributors

     925       685       731  
    


 


 


       10,629       13,138       10,437  

Less: reserve for slow-moving, excess and obsolete inventory

     (5,172 )     (9,199 )     (4,863 )
    


 


 


     $ 5,457     $ 3,939     $ 5,574  
    


 


 


Property and equipment, net:

                        

Furniture and fixtures

   $ 100     $ 221     $ 221  

Software

     4,273       4,265       4,175  

Equipment

     3,908       4,749       4,233  

Leasehold improvements

     152       152       152  
    


 


 


       8,433       9,387       8,781  

Less: accumulated depreciation and amortization

     (7,558 )     (7,713 )     (6,884 )
    


 


 


     $ 875     $ 1,674     $ 1,897  
    


 


 


 

Property and equipment includes assets under capital leases and accumulated amortization of assets under capital leases of $1,853,000, $1,217,000 and $925,000, at September 30, 2005, September 30, 2004 and at December 31, 2003, respectively.

 

     September 30,
2005


  

September 30,
2004

Restated


   December 31,
2003


Accrued expenses:

                    

Accrued compensation and related benefits

   $ 394    $ 260    $ 218

Accrued audit fees

     214      123      95

Other accrued expenses

     2,291      381      289
    

  

  

     $ 2,899    $ 764    $ 602
    

  

  

 

19


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

NOTE 4—COMMON STOCK:

 

The Company’s Amended and Restated Articles of Incorporation authorize the Company to issue 100,000,000 shares of common stock. At September 30, 2005, September 30, 2004 and December 31, 2003, there were 55,410,722, 50,043,158 shares and 45,709,740 shares, respectively, of common stock issued and outstanding.

 

The Company has reserved the following number of shares of common stock for future issuance (in thousands):

 

     September 30,
2005


  

September 30,

2004


Common stock warrants

   968    16

Common stock under Employee Stock Purchase Plan

   125    234

Common stock upon exercise of outstanding stock options

   10,403    11,418
    
  
     11,496    11,668
    
  

 

On January 24, 2002, the Company completed a financing in which it raised $21 million in gross proceeds through a private placement of non-voting Series A Preferred Stock and warrants, at $30 per unit to a group of investors, which was convertible into 13,999,000 shares of common stock and warrants to purchase 3,303,760 shares of common stock. Each share of Series A Preferred Stock was convertible into 20 shares of Common Stock (or an effective Common Stock price of $1.50 per share). Investors also received warrants to purchase up to an additional 20 percent of shares of Series A Preferred Stock. The warrants have a term of three years and an exercise price equal to $39.00 per share (or an effective Common Stock exercise price of $1.95 per share).

 

At a Special Meeting of Stockholders held on March 7, 2002, the stockholders approved the issuance and sale of 699,950 shares of Series A Preferred Stock and warrants. The Series A Preferred Stock and warrants were not convertible until receipt of such stockholder approval. As a result, the Preferred Stock and warrants automatically converted into 13,999,000 shares of common stock and warrants to purchase 3,303,760 shares of common stock.

 

As a result of the favorable conversion price of the preferred shares at the date of issuance, the Company recorded accretion of approximately $15 million (thus increasing the “net loss applicable to common stockholders” for the year ended December 31, 2002) relating to the beneficial conversion feature representing the difference between the accounting conversion price and the fair value of the common stock on the date of the transaction, after valuing the warrants issued in connection with the financing transaction. The Company valued the warrants using the Black-Scholes option pricing model, applying an expected life of three years, a weighted average risk-free rate of 3.61 percent, an expected dividend yield of zero percent, a volatility of 130 percent and a deemed fair value of common stock of $2.35, which was the value of the Company’s common stock on the date of grant.

 

In August 2004 the Company completed a financing through the sale of 2,500,000 shares of common stock at a price of $2.00 per share.

 

In March 2005 the Company completed a financing through the sale of 4,833,336 shares of common stock at a price of $0.91 per share in a private placement. In connection with this private placement, the Company also issued warrants to purchase up to 966,667 shares of common stock with an exercise price of $1.25 per share.

 

20


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Stock Repurchase Program

 

In August 2002, the Company’s Board of Directors approved a Stock Repurchase Program and authorized the repurchase of up to one million shares of the Company’s common stock in the open market over the next year. No shares have been repurchased under the Stock Repurchase Program.

 

Common stock warrants

 

In connection with the financing that was completed on January 24, 2002, the Company issued warrants to purchase 3,303,760 shares of the Company’s common stock. This included unregistered warrants that were issued to the placement agent for the financing transaction to purchase 503,960 shares of the Company’s common stock. The 2,799,800 registered warrants had a term of three years and an effective Common Stock exercise price of $1.95 per share, whereas 419,968 of the 503,960 warrants issued to the placement agent had an effective Common Stock exercise price of $1.50 per share. The remainder of the warrants issued to the placement agent had an effective Common Stock exercise price of $1.95 per share. As discussed below, all of these warrants have been exercised.

 

During the year ended December 31, 2003, warrants were exercised which resulted in the issuance of 1,896,226 shares of the Company’s common stock with proceeds to the Company totaling approximately $3.1 million. These amounts included the exercise of warrants issued to the placement agent on a cashless net issuance basis resulting in 300,438 shares of the Company’s common stock being issued to the placement agent.

 

The warrant agreement contained a provision for the mandatory exercise of the warrants if the Company’s common stock traded at $5.85 or higher for 20 out of 30 trading days. At the close of business on January 2, 2004 the Company’s common stock had traded at $5.85 or higher for 20 consecutive days and the Company was able to invoke the provision for the mandatory exercise of all outstanding warrants issued in connection with the January 2002 financing. All outstanding warrants were exercised in January 2004 resulting in the issuance of an additional 1.2 million shares of common stock. The Company received proceeds of approximately $2.3 million from the exercise of these warrants.

 

During the nine months ended September 30, 2004 all the remaining warrants issued in connection with the 2002 private placement were exercised which resulted in the issuance of 1,211,000 shares of the Company common stock with proceeds to the Company totaling approximately $2.3 million in January 2004.

 

On March 3, 2005, the Company completed a private placement which resulted in gross proceeds of $4.4 million. In connection with this private placement the Company sold 4,833,335 shares of common stock at a price of $0.90 per share and issued warrants to purchase up to 966,667 shares of common stock. The warrants have a term of 3.5 years and an exercise price equal to $1.25. Since the warrants are subject to certain registration rights, the Company recorded a warrant liability, totaling $967,000, in accordance with EITF 00-19 “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock”. The warrant liability has subsequently been recalculated using the closing price of the Company’s common stock as of September 30, 2005 of $0.68. The registration rights provide for the Company to file with the Securities and Exchange Commission a Registration Statement covering the resale of all of the securities issued in connection with the private placement. The registration statement was filed with the Securities and Exchange Commission on March 24, 2005. We were required to have received an effective registration no later than 30 days after the Closing date. If the registration was not effective by that time we incurred penalties. The registration became effective on September 12, 2005, and we do not anticipate any future penalties associated with the registration. The Company valued the warrants using the Black-Scholes option pricing model, applying a life of 3.5 years, a risk free interest rate of 4.02%, an expected dividend yield of 0%, a volatility of 154% and a deemed fair value of

 

21


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

common stock of $1.17 which was the closing price of the Company’s common stock on March 3, 2005. In accordance with SFAS 133 “Accounting for Derivative Instruments and Hedging Activities”, the Company revalued the warrants as of September 30, 2005 using the Black-Scholes option pricing model. Assumptions regarding the life, the expected dividend yield and volatility were left unchanged but the Company did apply a risk free interest rate of 4.13% and a deemed fair value of common stock of $0.68, which was the closing price of the Company’s common stock on September 30, 2005. The difference between the fair value of the warrants as of September 30, 2005 and the previous valuation as of June 30, 2005 has been recorded as a change in fair value on revaluation of warrant liability.

 

Restricted stock

 

In April 2003, the Company issued 1.8 million shares of restricted stock, pursuant to the 2000 Stock Plan. The Company determined the value of the restricted stock grant to be $324,000 by reference to the quoted market price at the time of issuance and is amortizing this amount over two years. Compensation expense related to the issuance of restricted stock was $94,000, $122,000 and $108,000 for the year ended September 30, 2005, the nine months ended September 30, 2004 and year ended December 31, 2003, respectively.

 

NOTE 5—EMPLOYEE BENEFIT PLANS:

 

Stock Option Plans

 

In April 2000, the Company adopted the 2000 Stock Option Plan (the “2000 Plan”). Upon adoption of the 2000 Plan, shares reserved for issuance under the 1995 Stock Option Plan relating to un-granted options were cancelled, and outstanding options under the 1995 Plan became subject to the 2000 Plan. The 2000 Plan authorizes the Board of Directors to grant incentive stock options (“ISOs”) and non-statutory stock options (“NSOs”) to employees, directors and consultants for up to 19,300,000 shares of common stock. ISOs may be granted only to employees of the Company (including officers and directors who are also employees). NSOs may be granted to employees, non-employee directors and consultants of the Company. No person will be eligible to receive more than 500,000 shares in any fiscal year pursuant to awards under the 2000 Plan other than a new employee of the Company who will be eligible to receive no more than 1,000,000 shares in the fiscal year in which such employee commences employment.

 

Under the 2000 Plan, ISOs and NSOs are granted at a price that is not to be less than 100 percent of the fair market value of the common stock on the date of grant, as determined by the Board of Directors. Initial hire-on stock options generally vest at 25 percent on the first anniversary date from the date of grant and then monthly thereafter over the remaining 36 months. Subsequent discretionary stock options, generally vest equally each month over 48 months. Options granted to shareholders who own more than 10 percent of the outstanding stock of the Company at the time of grant must be issued at prices not less than 110 percent of the estimated fair value of the stock on the date of grant. Options under the 2000 Plan may be granted for periods up to 10 years.

 

22


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

The following table summarizes stock option activity under the Company’s Stock Option Plans (in thousands, except per share data):

 

           Options Outstanding

     Options
Available
for Grant


    Shares

   

Weighted Average
Exercise Price

Per Share


Balance at December 31, 2002

   6,219     7,535     $ 2.88

Granted

   (2,955 )   2,955     $ 0.83

Grant of restricted stock

   (1,800 )   —         —  

Additional shares reserved

   2,000     —         —  

Canceled

   1,329     (1,329 )   $ 2.53

Exercised

   —       (660 )   $ 0.72
    

 

     

Balance at December 31, 2003

   4,793     8,501     $ 2.40

Granted

   (3,975 )   3,975     $ 1.61

Additional shares reserved

   2,000     —         —  

Canceled

   523     (523 )   $ 1.16

Exercised

   —       (535 )   $ 0.65
    

 

     

Balance at September 30, 2004

   3,341     11,418     $ 2.25

Granted

   (1,055 )   1,055     $ 1.10

Additional shares reserved

   —       —         —  

Canceled

   1,645     (1,645 )   $ 1.70

Exercised

   —       (425 )   $ 0.33
    

 

     

Balance at September 30, 2005

   3,341     10,403     $ 2.20
    

 

     

 

Significant options groups outstanding at September 30, 2005 and related weighted average exercise prices and contractual life information are as follows:

 

     Options Outstanding

   Options Vested and
Exercisable


Range of Exercise Prices


  

Number

Outstanding


   Weighted
Average
Contractual
Life (Years)


   Weighted
Average
Exercise
Price Per
Share


   Number
Vested and
Exercisable


   Weighted
Average
Exercise
Price Per
Share


$  0.14–$  0.21

   1,677,126    6.4    $ 0.15    1,339,541    $ 0.15

$  0.22–$  2.50

   6,808,574    7.8    $ 1.01    3,369,020    $ 0.93

$  2.51–$  4.50

   832,357    7.2    $ 4.30    527,557    $ 4.37

$  4.51–$  8.00

   169,665    3.3    $ 6.05    169,665    $ 6.05

$  8.01–$12.00

   855,000    4.7    $ 11.97    855,000    $ 11.97

$12.01–$19.88

   55,000    5.2    $ 14.31    55,000    $ 14.31

$20.89–$22.35

   5,000    5.0    $ 21.75    5,000    $ 21.75
    
              
      
     10,402,722    7.2    $ 2.20    6,320,783    $ 2.82
    
              
      

 

The weighted-average grant date fair value of options granted during the year ended September 30, 2005 was $1.10. The weighted-average grant date fair value of options granted during the nine months ended September 30, 2004 was $1.48. The total number of options exercisable as of December 31, 2003 was 3,732,080 and the weighted-average grant date fair value of options granted during the year ended December 31, 2003 was $0.71.

 

23


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

2000 Employee Stock Purchase Plan

 

In April 2000 the Company adopted the 2000 Employee Stock Purchase Plan (the “Purchase Plan”) under which 500,000 shares of common stock have been reserved for issuance. Eligible employees may elect to withhold up to 15 percent of their salary to purchase shares of the Company’s common stock at a price equal to 85 percent of the market value of the stock at the beginning or ending of a six month offering period, whichever is lower. No more than 5,000 shares may be purchased by an eligible employee during any calendar year. The Purchase Plan will terminate in 2010. Under the Purchase Plan, 109,705, 87,263, and 27,184 shares were issued during the year ended September 30, 2005, the nine months ended September 30, 2004, and year ended December 31, 2003, respectively.

 

The Company did not recognize compensation expense related to employee purchase rights in 2003.

 

401(k) Plan

 

The Company sponsors a 401(k) Plan (the “401(k) Plan”) which provides tax-deferred salary deductions for eligible employees. Employees may contribute up to 15 percent of their annual compensation to the 401(k) Plan, limited to a maximum annual amount as set periodically by the Internal Revenue Service. The 401(k) Plan permits, but does not require, the Company to make matching contributions. To date, no such matching contributions have been made.

 

NOTE 6—INCOME TAXES:

 

At September 30, 2005, the Company had net operating loss carry-forwards for federal and state income tax purposes of approximately $126,800,000 and $46,200,000 respectively, which expire in varying amounts beginning in 2008 through 2026. In addition, the Company has credit carry-forwards of approximately $4,800,000 for federal and state purposes. The federal and state carry-forwards expire in varying amounts through 2026. Under the Tax Reform Act of 1986, the amounts of and benefits from net operating loss and tax credit carry-forwards may be impaired or limited in certain circumstances. Events which could cause limitations in the use of net operating loss and tax credit carry-forwards that the Company may utilize in any one year include, but are not limited to, a cumulative ownership change of more than 50 percent, as defined, over a three-year period.

 

     September 30,
2005


    September 30,
2004


 

Deferred taxes comprise the following (in thousands):

                

Net operating loss carry-forwards

   $ 45,807     $ 41,086  

Non-deductible reserves and accruals

     3,235       5,113  

Credit carry-forwards

     4,294       4,321  

Capitalized research and development

     2,497       2,934  

Depreciation

     182       427  
    


 


Net deferred tax assets

     56,015       53,881  

Less: Valuation allowance

     (56,015 )     (53,881 )
    


 


Net deferred tax assets

   $ —       $ —    
    


 


 

The Company believes that, based on number of factors, the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred tax assets such that a full valuation allowance has been recorded. These factors include the Company’s history of losses, and relatively high expense levels, the fact that the market in which the Company competes is intensely competitive and characterized by rapidly changing

 

24


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

technology, the lack of carry-back capacity to realize deferred tax assets and the uncertainty regarding market acceptance of the Company’s products. The Company will continue to assess the realizability of the deferred tax assets based on actual and forecasted operating results. Deferred tax assets related to items effecting equity will be charged to equity when realized.

 

Income tax expense differed from the amounts computed by applying the statutory federal income tax rate of 34 percent to pretax income as a result of the following (in thousands):

 

     September 30,
2005


    September 30,
2004


 

Federal tax at statutory rate

   $ (3,690 )   $ (4,282 )

Amortization of intangibles

     73       83  

Net operating loss not benefited

     3,572       4,147  

Nondeductible expenses

     11       8  

Nondeductible stock compensation

     34       44  
    


 


Total income tax expense

   $ —       $ —    
    


 


 

NOTE 7—COMMITMENTS AND CONTINGENCIES:

 

Lease commitments

 

The Company leases office space and equipment under non-cancelable operating leases with various expiration dates through 2007. Rent expense for operating leases was as follows (in thousands):

 

     Year Ended
September 30,
2005


   Nine Months
Ended
September 30,
2004


   Year Ended
December 31,
2003


Rent expense

   $ 829    $ 619    $ 837

 

On July 18, 2002, the Company entered into a sublease agreement for the lease of new office space. Under the terms of the sublease agreement, commencing September 1, 2002 the Company became entitled to free rent until June 30, 2003. Subsequently, the Company will make monthly payments ranging from $0.65 per square foot to $1.35 per square foot until the sublease expires on March 31, 2007. As a result, the Company recorded its rent expense on a straight line basis and had $737,000 and $697,000 of deferred rent at September 30, 2004 and December 31, 2003, respectively.

 

On November 30, 2003, the Company entered into a capital lease for test equipment. The lease has a term of 38 months and at the end of the lease the Company may purchase the test equipment for $1.00. The Company may also purchase the test equipment after 14 months for $166,000 or after 20 months for $133,000.

 

Future minimum lease payments under non-cancelable operating leases and capital leases are as follows (in thousands):

 

Year Ending September 30,


   Operating Leases

   Capital Leases

 

2006

   $ 1,189    $ 222  

2007

     568      21  

2008

     5      —    

2009

     —        —    

2010 and beyond

     —        —    
    

  


Total minimum lease payments

   $ 1,762      243  
    

  


Less: amount representing interest

            (8 )
           


Present value of minimum lease payments

            235  

Less: current portion of capital lease obligations

            (490 )
           


Long-term capital lease obligations

          $ (255 )
           


 

25


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Inventory purchase commitments

 

At September 30, 2005 the Company had open purchase orders for the purchase of inventory totaling approximately $3.3 million. These purchase orders may only be cancelled if the foundry has not yet started production of the wafers to which the open purchase orders relate.

 

Contingencies

 

From time to time, in the normal course of business, various claims are made against the Company, its directors or officers. The Company has agreed to indemnify its officers and directors with respect to such claims, except in limited circumstances. For more information regarding the Company’s indemnification obligations and pending litigation please see “Guarantees” below in this Note 7 and see Note 8 below.

 

Guarantees

 

In November 2002, the FASB issued FIN No. 45 “Guarantor’s Accounting and Disclosure Requirements for Guarantees, including Indirect Guarantees of Indebtedness of Others—an interpretation of FASB Statements No. 5, 57 and 107 and rescission of FIN 34.” The following is a summary of the Company’s agreements that the Company has determined are within the scope of FIN 45.

 

The Company provides a limited warranty for up to one year for any defective products. During the year ended September 30, 2005, the nine months ended September 30, 2004 and year ended December 31, 2003, warranty expense was insignificant. The Company has a reserve for warranty costs of $20,000, which has not changed in the past year.

 

In March 2004, the Company entered into a Security Agreement to provide collateral for outstanding standby letters of credit which totaled $0.7 million at September 30, 2004. During 2005 one of these letters of credit expired and was not renewed. The second letter of credit for $0.2 million remains in place at September 30, 2005.

 

Pursuant to its bylaws, the Company has agreed to indemnify its officers and directors for certain events or occurrences arising as a result of the officer or director serving in such capacity. The term of the indemnification period is for the officer’s or director’s lifetime. To date, the Company has not incurred any costs in connection with these indemnification agreements. Accordingly, the Company has no liabilities recorded for these agreements as of September 30, 2005. The Company is self-insured for these and similar claims. The lawsuits described below in Note 8 involve claims that may be covered by these indemnification agreements.

 

The Company enters into indemnification provisions under (i) its agreements with other companies in its ordinary course of business, typically with business partners, contractors and customers, its sub-landlord and (ii) its agreements with investors. Under these provisions the Company has agreed to generally indemnify and hold harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of the Company’s activities or, in some cases, as a result of the indemnified party’s activities under the agreement. These indemnification provisions often include indemnifications relating to representations made by the Company with regard to intellectual property rights. These indemnification provisions generally survive termination of the underlying agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification provisions is unlimited. To date, the Company has not incurred any costs in connection with these indemnification agreements. Accordingly, the Company has no liabilities recorded for these agreements as of September 30, 2005.

 

26


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

NOTE 8—LITIGATION:

 

We are a party to lawsuits in the normal course of our business. Litigation in general, and securities litigation in particular, can be expensive and disruptive to normal business operations. Moreover, the results of legal proceedings are difficult to predict. An unfavorable resolution of one or more of these lawsuits would materially adversely affect our business, results of operations, or financial condition. In addition, given our financial condition and that we do not have insurance to offset the cost of litigation, the costs of defending one or more of these lawsuits will likely adversely affect our financial condition. We cannot estimate the loss or range of loss that may be reasonably possible for any of the contingencies described and accordingly have not recorded any associated liabilities in our consolidated balance sheets. We accrue legal costs when incurred.

 

Federal Securities Class Actions

 

Beginning on November 4, 2004, plaintiffs filed four separate complaints purporting to be class actions in the United States District Court for the Northern District of California alleging that we and certain of our present or former officers and/or directors, Dr. Adya S. Tripathi, David Eichler and Graham Wright, violated Sections 10(b) and 20(a) of the Exchange Act. Plaintiffs purported to represent a putative class of shareholders who purchased or otherwise acquired Tripath securities between January 29, 2004 and October 22, 2004. The complaints contain varying allegations, including that we and the individual defendants made materially false and misleading statements with respect to our financial results and with respect to our business, prospects and operations in the our filings with the SEC, press releases and other disclosures. The complaints seek unspecified compensatory damages, attorneys’ fees, expert witness fees, costs and such other relief as may be awarded by the Court.

 

On December 22, 2004, the Court entered a stipulation and order consolidating all of these complaints and ordering that the defendants need not respond to any of these complaints until after plaintiffs file a consolidated complaint. On January 4, 2005, plaintiffs filed motions for the appointment of lead plaintiff. The Court, by Order dated January 28, 2005, appointed Robert Poteet as the sole lead plaintiff and approved Milberg Weiss Bershad & Schulman LLP as lead counsel.

 

On July 11, 2005, the Company entered into a Stipulation and Settlement Agreement (the “Stipulation”) which was filed with the Court on July 12, 2005. The settlement class consists of all persons who purchased the securities of Tripath between January 29, 2004 and June 13, 2005, inclusive. Under the terms of the Stipulation, the parties agreed that the class action will be dismissed in exchange for a payment of $200,000 in cash by Tripath and the issuance of 2.45 million shares of Tripath common stock which shall be exempt from registration pursuant to Section 3(a)(10) of the Securities Act. The Stipulation remains subject to the satisfaction of various conditions, including without limitation final approval of the Stipulation by the Court, including a finding that the 2.45 million shares of Tripath common stock to be issued are exempt from registration pursuant to Section 3(a)(1) of the Securities Act. On October 20, 2005, the Court entered a Preliminary Order for Notice and Hearing in Connection with Settlement Proceedings. The hearing for final approval of the settlement currently is scheduled for January 24, 2006. However, on December 14, 2005, the parties submitted a stipulation and proposed order revising dates for class notice and final approval of settlement to the Court which contemplates that the hearing for final approval of the settlement would be held on April 11, 2006. The stipulation and proposed order is pending before the Court. Approximately $1.8 million has been accrued for this matter.

 

Derivative Shareholder Litigation

 

On December 7, 2004, plaintiff Mildred Lyon filed a purported derivative action in Santa Clara Superior Court against us and the following present or former officers and/or directors of the Company, Dr. Adya S. Tripathi, David P. Eichler, Graham K. Wright, A.K. Acharya, Andy Jasuja and Y.S. Fu. This complaint appears to be based upon the same facts and circumstances as the federal class actions and makes the following

 

27


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

claims: violation of Section 25402 of the California Corporations Code, breach of fiduciary duty and misappropriation of information, abuse of control, gross mismanagement, waste of corporate assets and unjust enrichment. On this basis, the complaint seeks unspecified compensatory damages, treble damages under Section 25502.5(a) of the California Corporations Code, extraordinary equitable and/or injunctive relief, restitution and disgorgement, attorneys’ fees, expert witness fees, costs, and such other relief as may be ordered by the Court.

 

On December 27, 2004, the Court entered a stipulation and order extending the time for us to respond to the complaint to February 23, 2005. On February 16, 2005, the Court entered an order further extending the time for us to respond to the complaint to March 25, 2005. On March 10, 2005, the court ordered that the individual defendants shall have through and including April 25, 2005 to file any motions to quash and/or dismiss for lack of personal jurisdiction, and that all defendants shall have thirty (30) days from the date the court issues a ruling on any motions to quash and/or dismiss for lack of personal jurisdiction to respond to the complaint, or in the event that no such motions are brought, extended the time for all defendants to respond to the complaint to April 25, 2005.

 

On April 4, 2005, the Court ordered that all deadlines shall be stayed for Defendants filing any motions to quash and/or dismiss for lack of personal jurisdictions, or otherwise respond to the Complaint, until such date as the parties mutually designate to the Court for the Court’s approval. A Case Management Conference is scheduled for February 7, 2006 before the Court. The parties currently are engaged in settlement discussions.

 

Langley Securities Fraud Litigation

 

On or about June 2, 2005, plaintiff Langley Partners, L.P. (“Langley”) filed a complaint in the United States District Court for the Southern District of New York alleging claims against the Company, Dr. Adya Tripathi, the Company’s President and Chief Executive Officer, and David Eichler, the Company’s former Chief Financial Officer. Langley alleges that it entered into a stock purchase agreement with Tripath on or about August 2, 2004 in which Langley purchased 1 million shares of Tripath common stock at a purchase price of $2.00 per share. Langley also alleges that it consented to the receipt of the Company’s Prospectus dated August 2, 2004 and the accompanying Prospectus dated June 1, 2004 which specifically incorporated certain of the Company’s filings with the SEC from March through July 2004. The complaint generally alleges that the Company and the individual defendants made materially false and misleading statements with respect to the Company’s financial results and with respect to its business, prospects, internal accounting controls and design wins on Godzilla products in the Company’s filings with the SEC, press releases and other documents. The complaint alleges claims against the Company and the individual defendants for violations of Sections 10(b) and 20(a) of the Exchange Act, fraud, breach of contract, unjust enrichment and money had and received, rescission and violations of Sections 11 and 15 of the Securities Act. On this basis, the complaint seeks unspecified compensatory damages and restitution in an amount in excess of $2 million, rescission of the purchase agreement and a return of $2 million, unspecified punitive damages, costs and such other relief as may be awarded by the Court.

 

On October 6, 2005, the Court entered an Order granting the Company’s motion to transfer this action from the Southern District of New York to the United States District Court for the Northern District of California. On October 18, 2005, the action was transferred to the Northern District of California. On December 9, 2005, the Company and the individual defendants filed a motion to dismiss the complaint in its entirety which has been scheduled for hearing before the Court on February 10, 2006.

 

Changes in and Disagreements with Accountants

 

As previously disclosed in our current report on Form 8-K dated October 18, 2004 and filed on October 22, 2004, in October 2004, our former independent registered public accountants, BDO Seidman LLP, or BDO,

 

28


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

provided our Audit Committee with a letter citing what BDO asserted are two “material weaknesses” over our internal financial controls: one regarding the lack of effectiveness of our Audit Committee and the other regarding the lack of controls in place to estimate distributor returns in accordance with SFAS No. 48. Following discussions with our employees, representatives of BDO further orally advised us that BDO had concerns regarding the appropriate accounting for approximately $1.3 million of product that, upon our inquiries, one of our distributors, Macnica, or the Distributor, reported had been returned to the Distributor by the Distributor’s customers, or the Product Return. In response to both the letter and the verbal comments, the Audit Committee instructed our then-Chief Financial Officer to investigate this matter and report the findings to the Audit Committee. As a result of the litigation matters referenced above, we retained outside litigation counsel to represent us in responding to the aforementioned complaints. In addition, the Audit Committee and the then-Chief Financial Officer directed litigation counsel to further conduct an internal investigation into the verbal concerns raised by BDO regarding the Product Return. Separately, the Audit Committee, with the assistance of our then-Chief Financial Officer investigated BDO’s assertion regarding the lack of controls in place to estimate distributor returns.

 

The Audit Committee received an initial report from our litigation counsel on findings of the internal investigation on January 21, 2005 and requested additional investigation by litigation counsel. On January 25, 2005, litigation counsel made a supplemental report on the findings of the internal investigation to date. Following the presentation of such report, including discussion of the findings of the forensic accountant hired by the litigation counsel with the approval of the Audit Committee, the Audit Committee concluded that our Country Manager for the Japan Sales Office (who is no longer employed with us) agreed in an arrangement outside the formal paperwork of the transactions underlying the Product Return that the Distributor could return the products back to us at the Distributor’s discretion.

 

The Audit Committee investigation and discussion included a review of our compliance with Securities and Exchange Commission Staff Accounting Bulletin No. 104 “Revenue Recognition in Financial Statements, or SAB 104, as applied to the circumstances surrounding the Product Return. Under SAB 104, a requirement for revenue recognition is that all of the following criteria must be met: (1) there is persuasive evidence that an arrangement exists, (2) delivery of goods has occurred, (3) the sales price is fixed or determinable, and (4) collectibility is reasonably assured. In addition, pursuant to our revenue recognition policy, for sales to distributors, we defer recognition of revenue until such time that the distributor sells products to its customers based upon receipt of point-of-sales reports from the distributor. The internal investigation revealed that approximately $1.4 million of a sale of our product to the Distributor did not meet the foregoing criteria because our former employee had agreed that the Distributor could return the product at the Distributor’s discretion, which forms the basis of the Restatement. This former employee had on this occasion agreed to a term of sale that was outside of our standard practices and was not referenced in the documentation related to the sale submitted to our finance department. Given the discovery of this arrangement for the Distributor to return the product, the Audit Committee concluded on January 25, 2005 that we should restate certain financial information that was previously reported in our Form 10-Q for the quarter ended June 30, 2004 filed with the Securities and Exchange Commission on August 6, 2004. For more information regarding the Restatement, please see Note 9 of Notes to Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K. In addition, the Audit Committee approved certain changes to our internal controls over financial reporting as an additional remedial action in response to the report of our litigation counsel and our forensic accountant and to the report by our Chief Financial Officer.

 

As a result, the Audit Committee concluded on May 5, 2005 that we should restate certain financial information (the “Additional Restatement”) that was previously reported in our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2004, June 30, 2004 and December 31, 2004 as well as certain financial information for the quarter and transition period ended September 30, 2004 and that was previously reported in

 

29


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

our Transition Report. The Additional Restatement was based on the Audit Committee’s conclusion on such date that the Consolidated Balance Sheets as of March 31, 2004, June 30, 2004, September 30, 2004 and December 31, 2004 and the related Consolidated Statements of Operations for the three months ended March 31, 2004, the three and six months ended June 30, 2004, the nine month transition period ended September 30, 2004 and the three months ended December 31, 2004 should no longer be relied upon because of errors in such financial statements.

 

Following receipt of a final report on the internal investigation, the Audit Committee determined that the internal investigation had been completed on June 15, 2005. The internal investigation revealed errors in the Company’s financial statements for 2002 and 2003. Such errors included certain shipments between distributors rather than to end-customers which were not noted on applicable point-of-sales reports, inaccurate shipment dates on certain point-of-sales reports, and inaccurate quantities noted on certain point-of-sales reports. The Company reviewed these errors with reference to the guidelines set forth in SAB99. Based upon such review, the Company concluded that such errors were immaterial and thus would not result in a restatement of the 2002 or 2003 financial statements.

 

SEC Investigation

 

On or about November 9, 2004, the SEC requested that we voluntarily produce documents responsive to certain document requests in the investigation entitled In the Matter of Tripath Technology, Inc. On or about January 25, 2004, February 14, 2005, and February 16, 2005, the SEC made additional documents requests. On or about March 30, 2005, the SEC issued a subpoena to the Company seeking additional documents. We have produced documents in response to the SEC’s voluntary requests for documents as well as the subpoena. We have cooperated with the SEC in its review of these matters.

 

On February 24, 2005, the SEC, pursuant to Section 20(a) of the Securities Act and Section 21(a) of the Exchange Act, issued a formal order of private investigation to determine whether there have been any violations of Section 17(a) of the Securities Act and Sections 10(b), 13(a), 13(b)(2)(A), 13(b)(2)(B) and 13(b)(5) of the Exchange Act and Rules 10b-5, 12b-20, 13a-13, 13a-14, 13b2-1 and 13b2-2 thereunder.

 

NOTE 9—RESTATEMENT OF PREVIOUSLY REPORTED TRANSITION PERIOD FINANCIAL INFORMATION:

 

As originally described in the Company’s Current Report on Form 8-K dated October 18, 2004 and filed with the Securities and Exchange Commission on October 22, 2004 (the “Prior 8-K”), the Company’s Audit Committee initiated an internal investigation regarding certain purported product returns (the “Product Returns”) to one of the Company’s distributors, Macnica Japan (“Macnica”), by its customers. The Audit Committee investigation and discussion included a review of the Company’s compliance with Securities and Exchange Commission Staff Accounting Bulletin No. 104 “Revenue Recognition in Financial Statements” (“SAB 104”) as applied to the circumstances surrounding the Product Returns. Under SAB 104, a requirement for revenue recognition is that all of the following criteria must be met: (1) there is persuasive evidence that an arrangement exists, (2) delivery of goods has occurred, (3) the sales price is fixed or determinable, and (4) collectibility is reasonably assured. In accordance with SAB 104, the Company’s revenue recognition policy, for sales to distributors, requires that the Company defer recognition of revenue until such time that the distributor sells products to its customers based upon receipt of point-of-sales reports from the distributor. As of the Audit Committee’s determination on January 25, 2005, the internal investigation revealed that approximately $1.4 million of a sale of the Company’s product to Macnica did not meet the foregoing criteria because the Company’s Country Manager for the Japan Sales Office (who is no longer employed by the Company) had agreed that Macnica could return the product to the Company at Macnica’s

 

30


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

discretion. The Audit Committee determined that this former employee had agreed to a term of sale that was outside of the Company’s standard practices and was not referenced in the documentation related to the sale submitted to the Company’s finance department. Given the discovery of this arrangement for Macnica to return the product, the Company’s Audit Committee concluded that the Company should restate certain financial information that was previously reported in the Company’s Form 10-Q for the quarter ended June 30, 2004, filed with the Securities and Exchange Commission on August 6, 2004 (the “June 2004 Form 10-Q”) to properly reflect its revenue and related financial information for the referenced periods (the “Initial Restatement”). Accordingly, the Company advised in the Prior 8-K that the Consolidated Statement of Operations for the three months and six months ended June 30, 2004 and the Consolidated Balance Sheet as of June 30, 2004 included in the June 2004 Form 10-Q should no longer be relied upon. The financial impact of the Initial Restatement was reflected in the Company’s Transition Report on Form 10-K/T for the transition period ended September 30, 2004 filed with the Securities and Exchange Commission on February 3, 2005 (the “Transition Report”).

 

The Audit Committee directed that the internal investigation continue following reporting of the Initial Restatement. As a result of this further investigation, on May 5, 2005 the Audit Committee determined that additional sale transactions with Macnica, as well as with an additional distributor of the Company, Uniquest, did not meet the Company’s revenue recognition criteria and the requirements of SAB 104. In certain circumstances, the same former employee of the Company had agreed that Macnica could return the referenced product at Macnica’s discretion. This former employee had on these occasions agreed to a term of sale that was outside of the Company’s standard practices and was not referenced in the documentation related to the sale submitted to the Company’s finance department. In addition, the Audit Committee determined that, in certain other circumstances, Macnica had shipped product not to end customers but to other distributors and the Company had relied on point-of-sales reports submitted to the Company by Macnica that indicated the referenced product had been shipped to an end customer of Macnica when such product had only been shipped to other distributors. Recognition of revenue on sales between distributors instead of to the end customers is not permitted under the Company’s revenue recognition policies. Further, the Audit Committee determined that certain sales transactions with Uniquest did not meet the Company’s revenue recognition criteria and the requirements of SAB 104 because in certain circumstances, employees of Uniquest had incorrectly reported to the Company the date of shipments to end customers.

 

As a result, the Audit Committee concluded on May 5, 2005 that the Company should restate certain financial information (the “Additional Restatement”) that was previously reported in the Company’s Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2004, June 30, 2004 and December 31, 2004 as well as certain financial information for the quarter and transition period ended September 30, 2004 that was previously reported in the Company’s Transition Report. The Additional Restatement was based on the Audit Committee’s conclusion on such date that the Consolidated Balance Sheets as of March 31, 2004, June 30, 2004, September 30, 2004 and December 31, 2004 and the related Consolidated Statements of Operations for the three months ended March 31, 2004, the three and six months ended June 30, 2004, the nine month transition period ended September 30, 2004 and the three months ended December 31, 2004 should no longer be relied upon because of errors in such financial statements. The Additional Restatement was originally described in our Current Report on Form 8-K dated May 5, 2005 and filed with the Securities and Exchange Commission on May 11, 2005 and is reflected in the financial statements in this report.

 

Following receipt of a final report on the internal investigation, the Audit Committee determined that the internal investigation had been completed on June 15, 2005. The internal investigation revealed errors in the Company’s financial statements for 2002 and 2003. Such errors included certain shipments between distributors rather than to end-customers which were not noted on applicable point-of-sales reports, inaccurate shipment dates on certain point-of-sales reports, and inaccurate quantities noted on certain point-of-sales reports. The Company reviewed these errors with reference to the guidelines set forth in SAB99. Based upon such review, the

 

31


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Company concluded that such errors were immaterial and thus would not result in a restatement of the 2002 or 2003 financial statements.

 

The following table provides a reconciliation of amounts previously reported in the Company’s Transition Report on Form 10-K/T for the three and nine months ended September 30, 2004 with amounts adjusted for the Initial Restatement and the Additional Restatement.

 

Consolidated Statement of Operations

 

    

Three Months Ended

September 30, 2004


 
     Previously
Reported (1)


    Restatement
Adjustment


    Restated
Total


 

Net revenues

   $ 2,218     $ 1,077     $ 3,295  

Gross profit

     (4,085 )     356       (3,729 )

Operating loss

     (7,145 )     356       (6,789 )

Net loss

     (7,139 )     356       (6,783 )

Basic and diluted net loss per share

   $ (0.15 )           $ (0.14 )
    

Nine Months Ended

September 30, 2004


 
     Previously
Reported (1)


    Restatement
Adjustment


    Restated
Total


 

Revenue

   $ 9,421     $ (252 )(2)   $ 9,169  

Cost of revenue

     7,574       (159 )(3)     7,415  

Provision for slow-moving, excess and obsolete inventory

     4,316       —         4,316  
    


 


 


Gross loss

     (2,469 )     (93 )     (2,562 )
    


 


 


Operating expenses:

                        

Research and development

     5,521       —         5,521  

Selling, general and administrative

     3,556       —         3,556  
    


 


 


Total operating expenses

     9,077       —         9,077  

Loss from operations

     (11,546 )     (93 )     (11,639 )

Interest and other income (expense) net

     (26 )     —         26  
    


 


 


Net loss

   $ (11,572 )   $ (93 )   $ (11,665 )
    


 


 


 

32


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

     September 30, 2004

 
     Previously
Reported (1)


    Restatement
Adjustment


    Restated
Total


 

ASSETS

                        

Current assets:

                        

Cash, cash equivalents and restricted cash

   $ 7,339     $ —       $ 7,339  

Accounts receivable, net

     1,019       —         1,019  

Inventories, net

     3,780       159 (3)     3,939  

Prepaid expenses and other current assets

     212       —         212  
    


 


 


Total current assets

     12,350       159       12,509  

Property and equipment, net

     1,674       —         1,674  

Other assets

     123       —         123  
    


 


 


Total assets

   $ 14,147     $ 159     $ 14,306  
    


 


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                        

Current liabilities:

                        

Accounts payable

   $ 2,908     $ —       $ 2,908  

Current portion of capital lease obligations

     664       —         664  

Current portion of deferred rent

     266       —         266  

Accrued expenses

     764       —         764  

Deferred distributor revenue

     823       252 (2)     1,075  
    


 


 


Total current liabilities

     5,425       252       5,677  
    


 


 


Long term liabilities:

     471       —         571  
    


 


 


Stockholders’ equity:

                        

Common stock

     49       —         49  

Additional paid-in capital

     199,333       —         199,333  

Deferred stock-based compensation

     (95 )     —         (95 )

Accumulated deficit

     (191,136 )     (93 )     (191,229 )
    


 


 


Total stockholders’ equity

     8,151       (93 )     8,058  
    


 


 


Total liabilities and stockholders’ equity

   $ 14,147     $ 159     $ 14,306  
    


 


 



(1) As previously reported in the Company’s Transition Report on Form 10-K/T for the nine months ended September 30, 2004.
(2) Reflects the net cumulative deferral of revenue of approximately $252,000 relating to products subject to a right of return and product shipped not to end customers but to other distributors.
(3) Reflects a net cumulative increase in inventory of approximately $159,000 relating to the deferred cost associated with the deferred revenue.

 

Summarized quarterly financial information for the nine months ended September 30, 2004 and years ended December 31, 2003 and 2002 is as follows (in thousands, except per share data):

 

2004


   First
Quarter
Restated


    Second
Quarter
Restated


    Third
Quarter
Restated


 

Net revenues

   $ 3,273     $ 2,601     $ 3,295  

Provision for slow-moving, excess and obsolete inventory (Note 1)

   $ —       $ 254     $ 4,082  

Gross profit

   $ 900     $ 267     $ (3,729 )

Operating loss

   $ (2,087 )   $ (2,763 )   $ (6,789 )

Net loss

   $ (2,079 )   $ (2,803 )   $ (6,783 )

Basic and diluted net loss per share

   $ (0.05 )   $ (0.06 )   $ (0.14 )

 

Note 1. Provision for slow-moving, excess and obsolete inventory

 

During the quarter ended September 30, 2004 the Company recorded a provision for slow-moving, excess and obsolete inventory of approximately $4.3 million. The inventory charge related to slow-moving and excess inventory for the Company’s TA1101B, TA3020, TA2041, TA2022 and leaded TA2024 products, the TK2350, TK2051, TK2150, TK2050 and TK2052 chipsets, and Kauai 2BB and U461 die based on a decline in forecasted sales for these parts.

 

33


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Note 2. Accretion on preferred stock

 

On January 24, 2002, the Company completed a financing in which it raised $21 million in gross proceeds through a private placement of non-voting Series A Preferred Stock and warrants, at $30 per unit to a group of investors, which was convertible into 13,999,000 shares of common stock and warrants to purchase 3,303,760 shares of common stock. Each share of Series A Preferred Stock was convertible into 20 shares of Common Stock (or an effective Common Stock price of $1.50 per share). As a result of the favorable conversion price of the shares and related warrants at the date of issuance, the Company recorded accretion of approximately $15 million relating to the beneficial conversion feature representing the difference between the accounting conversion price and the fair value of the common stock on the date of the transaction, after valuing the warrants issued in connection with the financing transaction.

 

Nine months ended September 30, 2003 (unaudited)

 

The following information is being presented for comparative purposes since the Company changed its fiscal year end from December 31 to September 30, effective as of September 30, 2004.

 

     Nine Months Ended
September 30, 2003


 

Net revenues

   $ 9,765  

Gross profit

   $ 2,824  

Operating loss

   $ (5,843 )

Net loss

   $ (5,829 )

Basic and diluted net loss per share

   $ (0.14 )

 

NOTE 10—SUBSEQUENT EVENTS

 

In October 2005, the Company proposed amending the warrants issued as part of the March 2005 private placement to lower the exercise price to $0.50 per share, eliminate the cashless net exercise provision of the warrant, and advance the warrant termination date to October 14, 2005. On October 14, 2005, the holders of warrants to exercise 533,333 shares of the Company’s common stock agreed to the amendment and, as a result, the Company issued 533,333 shares of common stock upon the exercise of such amended warrants on October 14, 2005 for aggregate proceeds of $0.3 million. The remaining warrants to purchase 433,334 shares of common stock at and exercise price of $1.25 per share issued pursuant to the March 3, 2005 private placement are exercisable through September 4, 2008.

 

On November 8, 2005, the Company completed a private placement which resulted in gross proceeds of $5.0 million. In connection with this private placement the Company sold $5,000,000 in principal amount of 6% Senior Secured Convertible Debentures, convertible into common stock at a price of $0.37 per share (subject to certain adjustments), and issued Series A Warrants to purchase up to 6,756,755 shares of common stock at an exercise price of $0.37 per share and Series B Warrants to purchase up to 10,368,854 shares of common stock at an exercise price of $0.43 per share. The Series A Warrants are exercisable immediately and terminate upon the earlier of July 1, 2005 or 30 days after the effectiveness date of the registration statement contemplated in the November 2005 private placement transaction. The Series B Warrants are exercisable from May 8, 2006 until May 8, 2011.

 

34


Table of Contents

TRIPATH TECHNOLOGY INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

NOTE 11—SUPPLEMENTARY FINANCIAL INFORMATION (unaudited):

 

Summarized quarterly financial information for the year ended September 30, 2005, the nine months ended September 30, 2004 and year ended December 31, 2003 is as follows (in thousands, except per share data):

 

2005


   First
Quarter


    Second
Quarter


    Third
Quarter


    Fourth
Quarter


 

Net revenues

   $ 1,673     $ 2,728     $ 2,886     $ 3,474  

Gross profit

   $ 446     $ 1,738     $ 1,572     $ 1,720  

Operating loss

   $ (2,883 )   $ (2,014 )   $ (4,036 )   $ (1,590 )

Net loss

   $ (2,878 )   $ (1,778 )   $ (3,829 )   $ (1,487 )

Basic and diluted net loss per share

   $ (0.06 )   $ (0.03 )   $ (0.07 )   $ (0.03 )

2004


   First
Quarter
Restated


    Second
Quarter
Restated


    Third
Quarter
Restated


       

Net revenues

   $ 3,273     $ 2,601     $ 3,295          

Gross profit

   $ 900     $ 267     $ (3,729 )        

Operating loss

   $ (2,087 )   $ (2,763 )   $ (6,789 )        

Net loss

   $ (2,079 )   $ (2,803 )   $ (6,783 )        

Basic and diluted net loss per share

   $ (0.05 )   $ (0.06 )   $ (0.14 )        

2003


   First
Quarter


    Second
Quarter


    Third
Quarter


    Fourth
Quarter


 

Net revenues

   $ 2,952     $ 3,139     $ 3,674     $ 4,126  

Gross profit

   $ 745     $ 919     $ 1,160     $ 1,357  

Operating loss

   $ (2,479 )   $ (1,819 )   $ (1,545 )   $ (1,394 )

Net loss

   $ (2,477 )   $ (1,816 )   $ (1,536 )   $ (1,386 )

Basic and diluted net loss per share

   $ (0.06 )   $ (0.04 )   $ (0.04 )   $ (0.03 )

 

NOTE 12—EVENTS (UNAUDITED) SUBSEQUENT TO THE DATE OF THE REPORT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

On December 13, 2005, Tripath Technology Inc. terminated its Business Financing Agreement (the “Agreement”) with Bridge Bank, National Association (the “Bank”).

 

Pursuant to the terms of the Agreement, the Company is paying a $60,000 termination fee to the Bank to terminate the Agreement.

 

35


Table of Contents

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

(a) The following documents are filed as part of this Form 10-K:

 

(1) Financial Statements:

 

Report of Independent Registered Public Accounting Firm

 

Consolidated Balance Sheets as of September 30, 2005, September 30, 2004 and December 31, 2003

 

Consolidated Statements of Operations for the year ended September 30, 2005, the nine months ended September 30, 2004, and year ended December 31, 2003

 

Consolidated Statements of Stockholders’ Equity for the year ended September 30, 2005, the nine months ended September 30, 2004, and year ended December 31, 2003

 

Consolidated Statements of Cash Flows for the year ended September 30, 2005, the nine months ended September 30, 2004, and year ended December 31, 2003

 

Notes to Consolidated Financial Statements

 

(2) Financial Statement Schedules:

 

Financial statement schedules have been omitted since the required information is not present in amounts sufficient to require submission of the schedules or because the information required is included in the financial statements or notes thereto.

 

(3) Exhibits: The items listed on the Index to Exhibits on page 38 are incorporated herein by reference.

 

36


Table of Contents

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

TRIPATH TECHNOLOGY INC.

By:

 

/s/    DR. ADYA S. TRIPATHI        


   

Dr. Adya S. Tripathi

President and Chief Executive Officer,

Chairman of the Board

 

Dated: December 15, 2005

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature


  

Title


 

Date


/S/    DR. ADYA S. TRIPATHI        


Dr. Adya S. Tripathi

  

President and Chief Executive Officer (Principal Executive Officer)

  December 15, 2005

/S/    JEFFREY L. GARON        


Jeffrey L. Garon

  

Vice President, Finance and

Chief Financial Officer (Principal Financial and Accounting Officer)

  December 15, 2005

*


A.K. Acharya

  

Director

  December 15, 2005

*


Y.S. Fu

  

Director

  December 15, 2005

*


Andy Jasuja

  

Director

  December 15, 2005

*


Akifumi Goto

  

Director

  December 15, 2005
*By:  

/S/    DR. ADYA S. TRIPATHI        


Dr. Adya S. Tripathi

Pursuant to Powers of Attorney filed previously with the Securities and Exchange Commission

 

37


Table of Contents

EXHIBIT INDEX

 

Number

  

Description of Document


  3.1    Restated Certificate of Incorporation of Tripath Technology Inc. (incorporated by reference to Exhibit 3.1 of Tripath’s registration statement on Form S-1, registration number 333-35028, as amended)
  3.2    Bylaws of Tripath Technology Inc. (incorporated by reference to Exhibit 3.2 of Tripath’s transition report on Form 10-K/T, filed on February 3, 2005)
  4.1    Specimen common stock certificate (incorporated by reference to Exhibit 4.1 of Tripath’s registration statement on Form S-1, registration number 333-35028, as amended)
  4.2    Form of Common Stock Purchase Warrant, dated March 2, 1998 (incorporated by reference to Exhibit 4.2 of Tripath’s registration statement on Form S-1, registration number 333-123551, as amended)
  4.3    Second Amended and Restated Shareholder Rights Agreement, dated September 15, 1998, between Tripath Technology Inc. and Certain Stockholders of Tripath Technology Inc. (incorporated by reference to Exhibit 10.6 of Tripath’s registration statement on Form S-1, registration number 333-35028, as amended)
  4.4    Form of Common Stock Purchase Warrant, dated July 28, 2000 (incorporated by reference to Exhibit 4.4 of Tripath’s registration statement on Form S-1, registration number 333-123551, as amended)
  4.5    Registration Rights Agreement, dated January 24, 2002, by and among Tripath Technology Inc. and Certain Stockholders of Tripath Technology Inc. (incorporated by reference to Exhibit 4.1 of Tripath’s current report on Form 8-K filed on January 30, 2002)
  4.6    Registration Rights Agreement, dated March 3, 2005, by and among Tripath Technology Inc. and certain stockholders of Tripath Technology Inc. (incorporated by reference to Exhibit 4.6 of Tripath’s registration statement on Form S-1, registration number 333-123551, as amended)
  4.7    Form of Common Stock Purchase Warrant issued in connection with Securities Purchase Agreement, dated March 3, 2005, by and among Tripath Technology Inc. and certain stockholders of Tripath Technology Inc. (incorporated by reference to Exhibit 4.7 of Tripath’s registration statement on Form S-1, registration number 333-123551, as amended)
  4.8    Form of 6% Senior Secured Convertible Debenture issued in connection with Securities Purchase Agreement, dated November 8, 2005 by and among Tripath Technology Inc. and the signatories thereto (incorporated by reference to Exhibit 4.1 of Tripath’s current report on Form 8-K filed November 9, 2005)
  4.9    Form of Series A/Series B Common Stock Purchase Warrant issued in connection with Securities Purchase Agreement, dated November 8, 2005 by and among Tripath Technology Inc. and the signatories thereto (incorporated by reference to Exhibit 4.2 of Tripath’s current report on Form 8-K filed November 9, 2005)
  4.10    Registration Rights Agreement dated November 8, 2005 by and among Tripath Technology Inc. and the purchasers named in the Securities Purchase Agreement dated November 8, 2005 (incorporated by reference to Exhibit 4.3 of Tripath’s current report on Form 8-K filed November 9, 2005)
  9.1    Voting Agreement dated November 8, 2005 by Dr. Adya S. Tripathi (incorporated by reference to Exhibit 9.1 of Tripath’s current report on Form 8-K filed November 9, 2005).
10.1*    Form of Indemnification Agreement, between Tripath Technology Inc. and each of its directors and officers (incorporated by reference to Exhibit 10.1 of Tripath’s registration statement on Form S-1, registration number 333-35028, as amended)


Table of Contents
Number

  

Description of Document


10.2    License and Supply Agreement, dated July 9, 1999, between STMicroelectronics, Inc. and Tripath Technology Inc. (incorporated by reference to Exhibit 10.2 of Tripath’s registration statement on Form S-1, registration number 333-35028, as amended)
10.3*    1995 Stock Plan and form of option agreement (incorporated by reference to Exhibit 4.8 of Tripath’s registration statement on Form S-8, registration number 333-108178)
10.4*    2000 Stock Plan and form of option agreement (incorporated by reference to Tripath’s definitive proxy statement on Schedule 14A filed on May 19, 2003)
10.5*    2000 Employee Stock Purchase Plan, as amended (incorporated by reference to Exhibit 10.5 of Tripath’s quarterly report on Form 10-Q for the quarter ended September 30, 2003)
10.6*    Form of Restricted Stock Purchase Agreement between Tripath Technology Inc. and an Executive Officer. (incorporated by reference to Exhibit 10.6 of Tripath’s annual report on Form 10-K filed on March 9, 2004)
10.7    Sublease Agreement, dated July 18, 2002, between Nortel Networks, Inc. and Tripath Technology Inc. (incorporated by reference to Exhibit 10.11 of Tripath’s quarterly report on Form 10-Q for the quarter ended September 30, 2002)
10.8    Distributor Agreement, dated July 1, 1998 between Uniquest Corporation and Tripath Technology Inc. (incorporated by reference to Exhibit 10.8 of Tripath’s annual report on Form 10-K filed on March 9, 2004)
10.9    Distributor Agreement, dated February 3, 1999 between Macnica, Inc and Tripath Technology Inc. (incorporated by reference to Exhibit 10.9 of Tripath’s annual report on Form 10-K filed on March 9, 2004)
10.10    Security Agreement dated March 8, 2004 between Tripath Technology Inc. and Union Bank of California, N.A. (incorporated by reference to Exhibit 10.1 of Tripath’s quarterly report on Form 10-Q filed on May 21, 2004)
10.11    Form of Stock Purchase Agreement dated August 1, 2004 between Tripath Technology Inc. and certain investors of Tripath Technology Inc. (incorporated by reference to Exhibit 10.11 of Tripath’s transition report on Form 10-K/T, filed on February 3, 2005)
10.12    Severance Agreement and Release, dated March 2, 2005, between Tripath Technology Inc. and Clarke Seniff (incorporated by reference to Exhibit 10.1 of Tripath’s current report on Form 8-K filed on March 7, 2005)
10.13    Securities Purchase Agreement, dated March 3, 2005 by and among Tripath Technology Inc. and the signatories thereto (incorporated by reference to Exhibit 10.12 of Tripath’s registration statement on Form S-1, registration number 333-123551, as amended)
10.14    Business Financing Agreement, dated August 4, 2005 by and among Tripath Technology Inc. and Bridge Bank, National Association (incorporated by reference to Exhibit 10.14 of Tripath’s annual report on Form 10-K filed on December 7, 2005)
10.15    Intellectual Property Security Agreement, dated August 4, 2005 by and among Tripath Technology Inc. and Bridge Bank, National Association (incorporated by reference to Exhibit 10.15 of Tripath’s annual report on Form 10-K filed on December 7, 2005)
10.16    Securities Purchase Agreement, dated November 8, 2005 by and among Tripath Technology Inc. and the signatories thereto (incorporated by reference to Exhibit 10.1 of Tripath’s current report on Form 8-K filed on November 9, 2005)
10.17    Security Agreement dated November 8, 2005 by and among Tripath Technology Inc. and the Purchasers named in the Securities Purchase Agreement dated November 8, 2005 (incorporated by reference to Exhibit 10.2 of Tripath’s current report on Form 8-K filed on November 9, 2005)
16.1    Letter, dated as of April 17, 2003, from PricewaterhouseCoopers LLP regarding its concurrence with Tripath’s statement regarding change of accountants (incorporated by reference to Exhibit 16.2 of Tripath’s current report on Form 8-K filed April 17, 2003)


Table of Contents
Number

  

Description of Document


16.2    Letter, dated as of October 22, 2004, from BDO Seidman, LLP regarding its concurrence with Tripath’s statement regarding change of accountants (incorporated by reference to Exhibit 16.1 of Tripath’s current report on Form 8-K filed October 22, 2004).
21.1    List of subsidiaries of Tripath Technology Inc. (incorporated by reference to Exhibit 21.1 of Tripath’s transition report on Form 10-K/T, filed on February 3, 2005)
23.1    Consent of Stonefield Josephson Inc., Independent Registered Public Accounting Firm
24.1    Power of Attorney (incorporated by reference to the signature page of Tripath’s annual report on Form 10-K filed on December 7, 2005)
31.1    Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2    Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1    Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

* Indicates management contract or compensatory plan or arrangement.